No Detail Found!

Formulation, in-vitro evaluation and optimization of valsartan nano- lipid complex by Box-Behnken design

Author(s)
Magdy I Mohamed Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University,Cairo,Egypt
Hanaa A Mahmoud Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University,Cairo,Egypt
Amir I Mohamed Egyptian Military Medical Academy,,Egypt
Nesrin M Nabil Free Pharmacist,,Egypt
Mohamed A Kasssem Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University,Cairo,Egypt
Yousef A Elsherif Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Heliopolis University,,Egypt
Abstract
The antihypertensive drug valsartan, has an imperfect bioavailability due to its low solubility, permeability and excessive first pass hepatic metabolism. So, the goal of this article is to improve the physicochemical properties of valsartan to increase its bioavailability. In order to achieve this goal, valsartan- phospholipid complexsomes (VAL-PLC) were developed by the technique of solvent evaporation using Box-Behnken experimental design to optimize variables in the production process. The box- Behnken design revealed that the formula F3 prepared using 60% lipid percentage at 60 0C reaction temperature for 2h reaction time offered the optimum conditions for VAL-PLC preparation where the percent drug content reached 92.24%, average particle diameter was 189.17nm and polydispersity index was 0.289. Drug release experiment indicated that the dissolution of both raw valsartan and its commercial dosage form was dependent upon pH where it was extremely low at pH 1.2 and low in distilled water and it had a high dissolution at pH 6.8. On the contrary, the optimized VAL-PLC formula showed a high and pH-independent dissolution rate whatever the type of dissolution medium was. Therefore, it was concluded that valsartan-complexsomes may be considered as an encouraging approach for improving physicochemical properties and increasing bioavailability of valsartan.
Publication Details
Page(s) 1249-1260
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Valsartan, phospholipid, box-behnken design, complexsomes
0

Citations

0

Downloads

76

Views